Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA
Open Access
- 1 June 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (23)
Abstract
Significance: Pneumococcal infections are major contributors to morbidity and mortality worldwide. Introduction of pneumococcal conjugated vaccines (PCVs) into the childhood vaccination program has led to a decrease in invasive pneumococcal disease (IPD) in vaccinated children but concurrently to an increase of nonvaccine-type IPD, also in nonvaccinated age groups such as the elderly. Thus, novel vaccine approaches are urgently needed, especially for the elderly, targeting all pneumococci causing IPD. Here, we show that pneumococcal membrane particles (MPs) evoke a serotype-independent cross-protection against IPD. This protection is dependent on the presence of the two conserved lipoproteins MalX and PrsA. We suggest that MPs can be used for pneumococcal vaccine development.Keywords
Funding Information
- Family Erling Persson Foundation (Project)
- The Swedish Foundation for Strategic research SSF (BENVAC)
- the Swedish Research Council (2018-05798;2021-06394)
- Knut och Alice Wallenbergs Stiftelse (WCS)
- Torsten Söderbergs Stiftelse (Söderbergs akademiprofessur)
- Stockholms Läns Landsting (ALF-medel)
This publication has 39 references indexed in Scilit:
- Control of cell division in Streptococcus pneumoniae by the conserved Ser/Thr protein kinase StkPProceedings of the National Academy of Sciences, 2012
- LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent PeptidoglycanJournal of Biological Chemistry, 2012
- Natural Antibodies against Several Pneumococcal Virulence Proteins in Children during the Pre-Pneumococcal-Vaccine Era: the Generation R StudyInfection and Immunity, 2011
- BLAST+: architecture and applicationsBMC Bioinformatics, 2009
- Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expressionEMBO Molecular Medicine, 2009
- Pneumococcal Serotypes and Mortality following Invasive Pneumococcal Disease: A Population-Based Cohort StudyPLOS Medicine, 2009
- Characterization of Protective Mucosal and Systemic Immune Responses Elicited by Pneumococcal Surface Protein PspA and PspC Nasal Vaccines against a Respiratory Pneumococcal Challenge in MiceClinical and Vaccine Immunology, 2009
- Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesJournal of Experimental Medicine, 2007
- Contributions of Pneumolysin, Pneumococcal Surface Protein A (PspA), and PspC to Pathogenicity ofStreptococcus pneumoniaeD39 in a Mouse ModelInfection and Immunity, 2007
- Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal SerotypesPLOS Genetics, 2006